| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.40e-10 | 193 | 48 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.87e-10 | 197 | 48 | 9 | GO:0022834 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1F ANO2 PACC1 GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 5.58e-09 | 334 | 48 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | MAP kinase tyrosine phosphatase activity | 6.11e-09 | 10 | 48 | 4 | GO:0033550 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ATP5F1D CACNA1F ANO2 PACC1 GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 8.82e-09 | 459 | 48 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | protein tyrosine/threonine phosphatase activity | 9.58e-09 | 11 | 48 | 4 | GO:0008330 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine/serine/threonine phosphatase activity | 2.07e-08 | 13 | 48 | 4 | GO:0017017 | |
| GeneOntologyMolecularFunction | transporter activity | ATP5F1D SLC6A18 PITPNM3 SLC6A9 CACNA1F ANO2 PACC1 GRIN2B P2RX7 ATP8B2 CHRNA4 CHRNA5 CHRNB2 RYR3 GRAMD1A ITPR2 | 2.60e-08 | 1289 | 48 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP5F1D SLC6A18 SLC6A9 CACNA1F ANO2 PACC1 GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 2.95e-08 | 793 | 48 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | ATP5F1D CACNA1F ANO2 PACC1 GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 3.50e-08 | 525 | 48 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ATP5F1D CACNA1F ANO2 PACC1 GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 3.57e-08 | 526 | 48 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.15e-08 | 140 | 48 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 5.82e-08 | 43 | 48 | 5 | GO:0005231 | |
| GeneOntologyMolecularFunction | MAP kinase phosphatase activity | 8.77e-08 | 18 | 48 | 4 | GO:0033549 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | ATP5F1D CACNA1F GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 1.09e-07 | 343 | 48 | 9 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP5F1D SLC6A18 SLC6A9 CACNA1F GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 3.73e-07 | 664 | 48 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.12e-06 | 77 | 48 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP5F1D SLC6A18 SLC6A9 CACNA1F ANO2 PACC1 GRIN2B P2RX7 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 2.78e-06 | 1180 | 48 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | protein tyrosine/serine/threonine phosphatase activity | 3.39e-06 | 43 | 48 | 4 | GO:0008138 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 3.67e-06 | 13 | 48 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 8.66e-06 | 17 | 48 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.06e-05 | 57 | 48 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.30e-05 | 60 | 48 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.79e-05 | 65 | 48 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.79e-05 | 65 | 48 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 2.23e-05 | 23 | 48 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.15e-05 | 75 | 48 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 5.16e-05 | 85 | 48 | 4 | GO:0017018 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.59e-05 | 31 | 48 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 6.93e-05 | 758 | 48 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 7.33e-05 | 93 | 48 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 9.73e-05 | 100 | 48 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.09e-04 | 103 | 48 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 1.36e-04 | 109 | 48 | 4 | GO:0004722 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.60e-04 | 129 | 48 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.72e-04 | 151 | 48 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | phosphatase activity | 6.12e-04 | 287 | 48 | 5 | GO:0016791 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 7.00e-04 | 627 | 48 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 7.50e-04 | 74 | 48 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.28e-04 | 465 | 48 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.45e-04 | 18 | 48 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 8.45e-04 | 18 | 48 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 1.09e-03 | 189 | 48 | 4 | GO:0004721 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.25e-03 | 196 | 48 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.39e-03 | 23 | 48 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.96e-03 | 749 | 48 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.06e-03 | 28 | 48 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.06e-03 | 105 | 48 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.20e-03 | 29 | 48 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 2.28e-03 | 386 | 48 | 5 | GO:0042578 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.85e-03 | 33 | 48 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 2.98e-03 | 807 | 48 | 7 | GO:0016788 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 3.20e-03 | 35 | 48 | 2 | GO:0051019 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.37e-03 | 125 | 48 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.57e-03 | 37 | 48 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 4.37e-03 | 41 | 48 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR52E4 OR10A7 GRIN2B P2RX7 OR10J1 CHRNA4 CHRNA5 CHRNB2 GPR75 | 4.45e-03 | 1353 | 48 | 9 | GO:0004888 |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 5.47e-03 | 46 | 48 | 2 | GO:0050997 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.72e-03 | 151 | 48 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 6.44e-03 | 50 | 48 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 6.69e-03 | 51 | 48 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 8.05e-03 | 171 | 48 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 8.30e-03 | 57 | 48 | 2 | GO:0120013 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.23e-02 | 70 | 48 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | amino acid binding | 1.33e-02 | 73 | 48 | 2 | GO:0016597 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP5F1D SLC6A18 SLC6A9 CACNA1F ANO2 PACC1 GRIN2B P2RX7 ATP8B2 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 1.44e-07 | 1115 | 48 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP5F1D SLC6A18 SLC6A9 CACNA1F ANO2 PACC1 FTH1P19 GRIN2B P2RX7 ATP8B2 CHRNA4 CHRNA5 CHRNB2 RYR3 ITPR2 | 2.82e-07 | 1374 | 48 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 4.77e-07 | 67 | 48 | 5 | GO:0099171 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 1.14e-06 | 34 | 48 | 4 | GO:0035335 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 1.93e-06 | 11 | 48 | 3 | GO:0035095 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 4.47e-06 | 105 | 48 | 5 | GO:0019233 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.05e-05 | 125 | 48 | 5 | GO:0051952 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.27e-05 | 130 | 48 | 5 | GO:0060079 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.39e-05 | 63 | 48 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | amine transport | 1.64e-05 | 137 | 48 | 5 | GO:0015837 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 2.30e-05 | 147 | 48 | 5 | GO:0099565 | |
| GeneOntologyBiologicalProcess | behavior | DERL2 GRIN2B CSMD1 ADCY1 PTGS1 CHRNA4 CHRNA5 CHRNB2 DNAH11 EIF4G1 | 3.16e-05 | 891 | 48 | 10 | GO:0007610 |
| GeneOntologyBiologicalProcess | cognition | 5.17e-05 | 423 | 48 | 7 | GO:0050890 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP5F1D SLC6A18 SLC6A9 CACNA1F FTH1P19 GRIN2B P2RX7 CHRNA4 CHRNB2 RYR3 ITPR2 | 5.47e-05 | 1157 | 48 | 11 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 6.05e-05 | 180 | 48 | 5 | GO:0060078 | |
| GeneOntologyBiologicalProcess | memory | 6.54e-05 | 183 | 48 | 5 | GO:0007613 | |
| GeneOntologyBiologicalProcess | response to alcohol | 8.21e-05 | 312 | 48 | 6 | GO:0097305 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A18 SLC6A9 CACNA1F FTH1P19 GRIN2B P2RX7 CHRNA4 CHRNB2 RYR3 ITPR2 | 8.34e-05 | 1000 | 48 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP5F1D SLC6A18 SLC6A9 CACNA1F ANO2 PACC1 GRIN2B P2RX7 RYR3 ITPR2 | 9.60e-05 | 1017 | 48 | 10 | GO:0098660 |
| GeneOntologyBiologicalProcess | negative regulation of MAPK cascade | 1.02e-04 | 201 | 48 | 5 | GO:0043409 | |
| GeneOntologyBiologicalProcess | action potential | 1.02e-04 | 201 | 48 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | signal release | 1.19e-04 | 653 | 48 | 8 | GO:0023061 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.32e-04 | 663 | 48 | 8 | GO:0050804 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.33e-04 | 112 | 48 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.34e-04 | 664 | 48 | 8 | GO:0099177 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.46e-04 | 217 | 48 | 5 | GO:0097553 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 1.46e-04 | 44 | 48 | 3 | GO:0007271 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.64e-04 | 509 | 48 | 7 | GO:0006816 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.80e-04 | 121 | 48 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | endoderm formation | 2.02e-04 | 49 | 48 | 3 | GO:0001706 | |
| GeneOntologyBiologicalProcess | learning or memory | 2.17e-04 | 373 | 48 | 6 | GO:0007611 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 2.28e-04 | 51 | 48 | 3 | GO:0095500 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 2.55e-04 | 53 | 48 | 3 | GO:1905145 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 2.80e-04 | 740 | 48 | 8 | GO:1903530 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 3.01e-04 | 56 | 48 | 3 | GO:1905144 | |
| GeneOntologyBiologicalProcess | response to nicotine | 3.34e-04 | 58 | 48 | 3 | GO:0035094 | |
| GeneOntologyBiologicalProcess | positive regulation of amine transport | 3.34e-04 | 58 | 48 | 3 | GO:0051954 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 4.75e-04 | 801 | 48 | 8 | GO:0051046 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 5.10e-04 | 67 | 48 | 3 | GO:0050433 | |
| GeneOntologyBiologicalProcess | response to ethanol | 5.33e-04 | 161 | 48 | 4 | GO:0045471 | |
| GeneOntologyBiologicalProcess | positive regulation of glutamate secretion | 5.46e-04 | 15 | 48 | 2 | GO:0014049 | |
| GeneOntologyBiologicalProcess | regulation of neuronal action potential | 5.46e-04 | 15 | 48 | 2 | GO:0098908 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 5.56e-04 | 69 | 48 | 3 | GO:0098926 | |
| GeneOntologyBiologicalProcess | secretion by cell | 6.80e-04 | 1064 | 48 | 9 | GO:0032940 | |
| GeneOntologyBiologicalProcess | sensory perception | OR52E4 CACNA1F OR10A7 GRIN2B P2RX7 OR10J1 CHRNA4 CHRNA5 CHRNB2 | 7.17e-04 | 1072 | 48 | 9 | GO:0007600 |
| GeneOntologyBiologicalProcess | catecholamine secretion | 8.26e-04 | 79 | 48 | 3 | GO:0050432 | |
| GeneOntologyBiologicalProcess | suckling behavior | 8.84e-04 | 19 | 48 | 2 | GO:0001967 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 1.08e-03 | 21 | 48 | 2 | GO:0071318 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.09e-03 | 195 | 48 | 4 | GO:0006865 | |
| GeneOntologyBiologicalProcess | endoderm development | 1.13e-03 | 88 | 48 | 3 | GO:0007492 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.19e-03 | 922 | 48 | 8 | GO:0098662 | |
| GeneOntologyBiologicalProcess | export from cell | 1.20e-03 | 1153 | 48 | 9 | GO:0140352 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.27e-03 | 931 | 48 | 8 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.27e-03 | 931 | 48 | 8 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.34e-03 | 939 | 48 | 8 | GO:0099537 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.36e-03 | 942 | 48 | 8 | GO:0098655 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.44e-03 | 359 | 48 | 5 | GO:0006874 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 1.45e-03 | 96 | 48 | 3 | GO:0051937 | |
| GeneOntologyBiologicalProcess | learning | 1.48e-03 | 212 | 48 | 4 | GO:0007612 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 1.66e-03 | 26 | 48 | 2 | GO:0050966 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 1.67e-03 | 752 | 48 | 7 | GO:1901699 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.71e-03 | 976 | 48 | 8 | GO:0099536 | |
| GeneOntologyBiologicalProcess | secretion | 1.79e-03 | 1221 | 48 | 9 | GO:0046903 | |
| GeneOntologyBiologicalProcess | regulation of glutamate secretion | 1.79e-03 | 27 | 48 | 2 | GO:0014048 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 1.79e-03 | 27 | 48 | 2 | GO:0060080 | |
| GeneOntologyBiologicalProcess | regulation of transmission of nerve impulse | 1.93e-03 | 28 | 48 | 2 | GO:0051969 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 1.93e-03 | 106 | 48 | 3 | GO:0015914 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 2.05e-03 | 389 | 48 | 5 | GO:0055074 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 2.09e-03 | 1249 | 48 | 9 | GO:0048878 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.12e-03 | 392 | 48 | 5 | GO:0070588 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 2.21e-03 | 582 | 48 | 6 | GO:0050906 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | 2.28e-03 | 795 | 48 | 7 | GO:1902532 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 2.37e-03 | 1272 | 48 | 9 | GO:1901698 | |
| GeneOntologyBiologicalProcess | monoamine transport | 2.49e-03 | 116 | 48 | 3 | GO:0015844 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.69e-07 | 378 | 48 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | transporter complex | ATP5F1D CACNA1F ANO2 PACC1 GRIN2B ATP8B2 CHRNA4 CHRNA5 CHRNB2 RYR3 | 3.90e-07 | 550 | 48 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.52e-06 | 523 | 48 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 9.05e-06 | 18 | 48 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | cholinergic synapse | 1.70e-05 | 22 | 48 | 3 | GO:0098981 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 1.70e-05 | 22 | 48 | 3 | GO:0098691 | |
| GeneOntologyCellularComponent | presynapse | SLC6A9 ANO2 GRIN2B P2RX7 FER1L5 ADCY1 CDH10 CHRNA4 CHRNA5 CHRNB2 | 2.68e-05 | 886 | 48 | 10 | GO:0098793 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.61e-05 | 405 | 48 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.94e-05 | 277 | 48 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.92e-05 | 583 | 48 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 9.57e-05 | 201 | 48 | 5 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynapse | 4.48e-04 | 1018 | 48 | 9 | GO:0098794 | |
| GeneOntologyCellularComponent | membrane protein complex | ATP5F1D CACNA1F ANO2 PACC1 GRIN2B SGCB CDH10 CHRNA4 CHRNA5 CHRNB2 RYR3 | 4.71e-04 | 1498 | 48 | 11 | GO:0098796 |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 4.91e-04 | 67 | 48 | 3 | GO:0098686 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 9.81e-04 | 503 | 48 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | non-motile cilium | 1.06e-03 | 196 | 48 | 4 | GO:0097730 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.97e-03 | 785 | 48 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 2.42e-03 | 1293 | 48 | 9 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 2.50e-03 | 1299 | 48 | 9 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 2.88e-03 | 1327 | 48 | 9 | GO:0042175 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 4.39e-03 | 43 | 48 | 2 | GO:0098688 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 4.80e-03 | 45 | 48 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | cell body | 5.02e-03 | 929 | 48 | 7 | GO:0044297 | |
| GeneOntologyCellularComponent | dynein complex | 6.85e-03 | 54 | 48 | 2 | GO:0030286 | |
| MousePheno | abnormal behavioral response to nicotine | 2.39e-05 | 3 | 40 | 2 | MP:0020160 | |
| MousePheno | abnormal nicotine-mediated receptor currents | 4.77e-05 | 4 | 40 | 2 | MP:0009475 | |
| MousePheno | disorganized barrel cortex | 7.94e-05 | 5 | 40 | 2 | MP:0000861 | |
| MousePheno | abnormal pain threshold | 1.02e-04 | 267 | 40 | 6 | MP:0001970 | |
| Domain | MKP | 6.11e-09 | 10 | 45 | 4 | IPR008343 | |
| Domain | RHOD | 2.08e-07 | 22 | 45 | 4 | SM00450 | |
| Domain | RHODANESE_3 | 2.52e-07 | 23 | 45 | 4 | PS50206 | |
| Domain | Rhodanese-like_dom | 3.02e-07 | 24 | 45 | 4 | IPR001763 | |
| Domain | - | 3.02e-07 | 24 | 45 | 4 | 3.40.250.10 | |
| Domain | Rhodanese | 3.02e-07 | 24 | 45 | 4 | PF00581 | |
| Domain | DUSP | 8.82e-07 | 31 | 45 | 4 | IPR024950 | |
| Domain | TYR_PHOSPHATASE_DUAL | 1.29e-06 | 34 | 45 | 4 | PS50054 | |
| Domain | DSPc | 1.46e-06 | 35 | 45 | 4 | SM00195 | |
| Domain | TYR_PHOSPHATASE_DUAL_dom | 1.46e-06 | 35 | 45 | 4 | IPR020422 | |
| Domain | Dual-sp_phosphatase_cat-dom | 2.79e-06 | 41 | 45 | 4 | IPR000340 | |
| Domain | DSPc | 2.79e-06 | 41 | 45 | 4 | PF00782 | |
| Domain | Nicotinic_acetylcholine_rcpt | 7.16e-06 | 16 | 45 | 3 | IPR002394 | |
| Domain | Acetylcholine_rcpt_TM | 2.24e-05 | 23 | 45 | 3 | IPR027361 | |
| Domain | - | 2.24e-05 | 23 | 45 | 3 | 1.20.120.370 | |
| Domain | TYR_PHOSPHATASE_1 | 5.41e-05 | 86 | 45 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 5.66e-05 | 87 | 45 | 4 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 5.66e-05 | 87 | 45 | 4 | IPR000387 | |
| Domain | - | 7.04e-05 | 92 | 45 | 4 | 3.90.190.10 | |
| Domain | RIH_assoc | 8.46e-05 | 6 | 45 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 8.46e-05 | 6 | 45 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 8.46e-05 | 6 | 45 | 2 | PF01365 | |
| Domain | RIH_dom | 8.46e-05 | 6 | 45 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.46e-05 | 6 | 45 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.46e-05 | 6 | 45 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 8.46e-05 | 6 | 45 | 2 | PF08709 | |
| Domain | - | 8.46e-05 | 6 | 45 | 2 | 1.25.10.30 | |
| Domain | Prot-tyrosine_phosphatase-like | 9.37e-05 | 99 | 45 | 4 | IPR029021 | |
| Domain | Dynein_heavy_dom-1 | 1.57e-04 | 8 | 45 | 2 | IPR013594 | |
| Domain | DHC_N1 | 1.57e-04 | 8 | 45 | 2 | PF08385 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.73e-04 | 45 | 45 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 1.85e-04 | 46 | 45 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 1.97e-04 | 47 | 45 | 3 | PF02931 | |
| Domain | Neur_channel | 1.97e-04 | 47 | 45 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.97e-04 | 47 | 45 | 3 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 1.97e-04 | 47 | 45 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.97e-04 | 47 | 45 | 3 | IPR006029 | |
| Domain | - | 1.97e-04 | 47 | 45 | 3 | 2.70.170.10 | |
| Domain | MIR | 2.52e-04 | 10 | 45 | 2 | PS50919 | |
| Domain | MIR | 2.52e-04 | 10 | 45 | 2 | PF02815 | |
| Domain | MIR | 2.52e-04 | 10 | 45 | 2 | SM00472 | |
| Domain | MIR_motif | 2.52e-04 | 10 | 45 | 2 | IPR016093 | |
| Domain | PTPc_motif | 3.87e-04 | 59 | 45 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.87e-04 | 59 | 45 | 3 | IPR003595 | |
| Domain | ATPase_dyneun-rel_AAA | 5.07e-04 | 14 | 45 | 2 | IPR011704 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.07e-04 | 14 | 45 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.07e-04 | 14 | 45 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.07e-04 | 14 | 45 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.07e-04 | 14 | 45 | 2 | PF08393 | |
| Domain | MT | 5.07e-04 | 14 | 45 | 2 | PF12777 | |
| Domain | AAA_8 | 5.07e-04 | 14 | 45 | 2 | PF12780 | |
| Domain | AAA_5 | 5.07e-04 | 14 | 45 | 2 | PF07728 | |
| Domain | DHC_fam | 5.84e-04 | 15 | 45 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 5.84e-04 | 15 | 45 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 5.84e-04 | 15 | 45 | 2 | PF03028 | |
| Domain | Tyr_Pase_AS | 7.23e-04 | 73 | 45 | 3 | IPR016130 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 8.47e-04 | 18 | 45 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 9.46e-04 | 19 | 45 | 2 | PS50267 | |
| Domain | SNF | 9.46e-04 | 19 | 45 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 9.46e-04 | 19 | 45 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 9.46e-04 | 19 | 45 | 2 | PS00610 | |
| Domain | Ion_trans_dom | 2.61e-03 | 114 | 45 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.61e-03 | 114 | 45 | 3 | PF00520 | |
| Domain | Sushi | 6.97e-03 | 52 | 45 | 2 | PF00084 | |
| Pathway | BIOCARTA_DSP_PATHWAY | 6.24e-09 | 9 | 39 | 4 | M22032 | |
| Pathway | BIOCARTA_DSP_PATHWAY | 6.24e-09 | 9 | 39 | 4 | MM1554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP | 2.35e-07 | 20 | 39 | 4 | M47928 | |
| Pathway | REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION | 3.53e-07 | 22 | 39 | 4 | MM14506 | |
| Pathway | REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION | 4.26e-07 | 23 | 39 | 4 | M26917 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.63e-06 | 9 | 39 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.63e-06 | 9 | 39 | 3 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.18e-06 | 11 | 39 | 3 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 4.23e-06 | 12 | 39 | 3 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 4.23e-06 | 12 | 39 | 3 | MM15312 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 5.19e-06 | 42 | 39 | 4 | MM15274 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 5.71e-06 | 43 | 39 | 4 | M27560 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 6.98e-06 | 14 | 39 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 8.71e-06 | 15 | 39 | 3 | MM14704 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 2.52e-05 | 21 | 39 | 3 | M39343 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.01e-05 | 74 | 39 | 4 | MM15962 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY | 7.42e-05 | 5 | 39 | 2 | M48978 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 8.88e-05 | 166 | 39 | 5 | M16024 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.23e-04 | 178 | 39 | 5 | M2890 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.55e-04 | 7 | 39 | 2 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.55e-04 | 7 | 39 | 2 | MM15311 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.39e-04 | 205 | 39 | 5 | M752 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 2.54e-04 | 327 | 39 | 6 | M27565 | |
| Pathway | WP_MAPK_SIGNALING | 5.51e-04 | 246 | 39 | 5 | M39597 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 5.71e-04 | 13 | 39 | 2 | MM14553 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 6.51e-04 | 144 | 39 | 4 | MM14501 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 7.98e-04 | 267 | 39 | 5 | M10792 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 8.39e-04 | 270 | 39 | 5 | M15514 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 8.68e-04 | 272 | 39 | 5 | M13380 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 8.73e-04 | 16 | 39 | 2 | M26945 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.43e-04 | 70 | 39 | 3 | M3115 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 1.24e-03 | 19 | 39 | 2 | M47793 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.24e-03 | 19 | 39 | 2 | M27362 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.24e-03 | 19 | 39 | 2 | M47760 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.24e-03 | 19 | 39 | 2 | MM15107 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 1.66e-03 | 22 | 39 | 2 | M22003 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.95e-03 | 90 | 39 | 3 | M835 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.51e-03 | 27 | 39 | 2 | MM15053 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.51e-03 | 27 | 39 | 2 | M47755 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.66e-03 | 211 | 39 | 4 | MM14502 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.69e-03 | 28 | 39 | 2 | M924 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.71e-03 | 101 | 39 | 3 | M1979 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 19139153 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 20881005 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 24144909 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 27645992 | ||
| Pubmed | Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain. | 9.86e-09 | 4 | 48 | 3 | 19481067 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 19482438 | ||
| Pubmed | Low ethanol concentration alters CHRNA5 RNA levels during early human development. | 2.46e-08 | 5 | 48 | 3 | 20438829 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 18178562 | ||
| Pubmed | α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion. | 4.92e-08 | 6 | 48 | 3 | 21485013 | |
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 8563774 | ||
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 9009220 | ||
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 8.60e-08 | 7 | 48 | 3 | 1505988 | |
| Pubmed | Dissection of behavior and psychiatric disorders using the mouse as a model. | 9.77e-08 | 31 | 48 | 4 | 10767319 | |
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 17559419 | ||
| Pubmed | Functional interaction between Lypd6 and nicotinic acetylcholine receptors. | 1.37e-07 | 8 | 48 | 3 | 27344019 | |
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 8906617 | ||
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 19228980 | ||
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 20736995 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 12225896 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 6.29e-07 | 118 | 48 | 5 | 19156168 | |
| Pubmed | 8.88e-07 | 14 | 48 | 3 | 23213462 | ||
| Pubmed | 8.88e-07 | 14 | 48 | 3 | 19059502 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 1.11e-06 | 15 | 48 | 3 | 8838678 | |
| Pubmed | 1.36e-06 | 16 | 48 | 3 | 19259974 | ||
| Pubmed | Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. | 1.87e-06 | 2 | 48 | 2 | 10235262 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27559543 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27698419 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26500498 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19620239 | ||
| Pubmed | Extracellular domain nicotinic acetylcholine receptors formed by alpha4 and beta2 subunits. | 1.87e-06 | 2 | 48 | 2 | 16174636 | |
| Pubmed | Properties of mutated murine alpha4beta2 nicotinic receptors linked to partial epilepsy. | 1.87e-06 | 2 | 48 | 2 | 18321647 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 31336892 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12681012 | ||
| Pubmed | The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs. | 1.87e-06 | 2 | 48 | 2 | 12871652 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25204653 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8663494 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15569257 | ||
| Pubmed | α4β2 nicotinic acetylcholine receptors intrinsically influence body weight in mice. | 1.87e-06 | 2 | 48 | 2 | 31881170 | |
| Pubmed | An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors. | 1.87e-06 | 2 | 48 | 2 | 25869137 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15788760 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21321393 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 28446611 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26858154 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23869214 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 31130483 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22072695 | ||
| Pubmed | [Molecular and genetic basis of idiopathic nocturnal frontal lobe epilepsy]. | 1.87e-06 | 2 | 48 | 2 | 12185808 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 25451094 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15154117 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22022466 | ||
| Pubmed | Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. | 1.87e-06 | 2 | 48 | 2 | 11226321 | |
| Pubmed | Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. | 1.87e-06 | 2 | 48 | 2 | 18043764 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21451042 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18331477 | ||
| Pubmed | Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy. | 1.87e-06 | 2 | 48 | 2 | 32536355 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26644472 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27895161 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 30414940 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26269589 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 29074617 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18095155 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23056257 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23843950 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16636791 | ||
| Pubmed | Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity. | 1.87e-06 | 2 | 48 | 2 | 24658355 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17226798 | ||
| Pubmed | Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density. | 1.87e-06 | 2 | 48 | 2 | 23429692 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24850280 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18762859 | ||
| Pubmed | Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR. | 1.87e-06 | 2 | 48 | 2 | 11261808 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23734673 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 30176987 | ||
| Pubmed | Structural principles of distinct assemblies of the human α4β2 nicotinic receptor. | 1.87e-06 | 2 | 48 | 2 | 29720657 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22030359 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15741168 | ||
| Pubmed | Unrestrained p38 MAPK activation in Dusp1/4 double-null mice induces cardiomyopathy. | 1.87e-06 | 2 | 48 | 2 | 22993413 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21252231 | ||
| Pubmed | NMR resolved multiple anesthetic binding sites in the TM domains of the α4β2 nAChR. | 1.87e-06 | 2 | 48 | 2 | 23000369 | |
| Pubmed | Nicotine upregulates its own receptors through enhanced intracellular maturation. | 1.87e-06 | 2 | 48 | 2 | 15944128 | |
| Pubmed | The fifth subunit of the (α4β2)2 β2 nicotinic ACh receptor modulates maximal ACh responses. | 1.87e-06 | 2 | 48 | 2 | 28600847 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19101612 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27793780 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24422997 | ||
| Pubmed | Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. | 1.87e-06 | 2 | 48 | 2 | 16023355 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17385675 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 11344259 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24982426 | ||
| Pubmed | The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open. | 1.87e-06 | 2 | 48 | 2 | 20649589 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26688111 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16183856 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27445102 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 33657187 | ||
| Pubmed | Structural characterization and agonist binding to human α4β2 nicotinic receptors. | 1.87e-06 | 2 | 48 | 2 | 21396349 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 21757735 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27012889 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23037950 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 11434511 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17401441 | ||
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 2.35e-06 | 19 | 48 | 3 | 17373692 | |
| Pubmed | 4.29e-06 | 23 | 48 | 3 | 23665221 | ||
| Interaction | P2RX2 interactions | 2.97e-07 | 70 | 41 | 5 | int:P2RX2 | |
| Interaction | CHRNA4 interactions | 7.85e-07 | 159 | 41 | 6 | int:CHRNA4 | |
| Interaction | CHRNA3 interactions | 1.15e-06 | 39 | 41 | 4 | int:CHRNA3 | |
| Interaction | CHRNB2 interactions | 2.05e-06 | 103 | 41 | 5 | int:CHRNB2 | |
| Interaction | CHRNB4 interactions | 1.37e-05 | 72 | 41 | 4 | int:CHRNB4 | |
| Interaction | ABHD14B interactions | 2.75e-05 | 29 | 41 | 3 | int:ABHD14B | |
| Interaction | CCR6 interactions | 3.18e-05 | 89 | 41 | 4 | int:CCR6 | |
| Interaction | HTR3A interactions | 6.78e-05 | 108 | 41 | 4 | int:HTR3A | |
| Interaction | PACC1 interactions | 9.89e-05 | 119 | 41 | 4 | int:PACC1 | |
| Cytoband | 12q24 | 3.16e-04 | 25 | 48 | 2 | 12q24 | |
| Cytoband | 1q21.3 | 6.73e-03 | 117 | 48 | 2 | 1q21.3 | |
| GeneFamily | MAP kinase phosphatases | 6.03e-09 | 11 | 39 | 4 | 895 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 5.10e-06 | 16 | 39 | 3 | 173 | |
| GeneFamily | Dyneins, axonemal | 6.04e-04 | 17 | 39 | 2 | 536 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.71e-03 | 57 | 39 | 2 | 1179 | |
| GeneFamily | Olfactory receptors, family 10 | 8.91e-03 | 66 | 39 | 2 | 157 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-09 | 184 | 48 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-09 | 184 | 48 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-09 | 184 | 48 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 8.86e-07 | 163 | 48 | 5 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-06 | 169 | 48 | 5 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-06 | 200 | 48 | 5 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.11e-05 | 151 | 48 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-05 | 154 | 48 | 4 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 160 | 48 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 160 | 48 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 3.14e-05 | 167 | 48 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-05 | 168 | 48 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 3.29e-05 | 169 | 48 | 4 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd8+_T_cell)|Lymphoid / shred on cell class and cell subclass (v4) | 3.36e-05 | 170 | 48 | 4 | 20fd1a312c81c1bf3c5d2d6caf9b578e6b7a4171 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 175 | 48 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 176 | 48 | 4 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.85e-05 | 176 | 48 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.02e-05 | 178 | 48 | 4 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.02e-05 | 178 | 48 | 4 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 4.02e-05 | 178 | 48 | 4 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-05 | 179 | 48 | 4 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-05 | 179 | 48 | 4 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 179 | 48 | 4 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 180 | 48 | 4 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 180 | 48 | 4 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 180 | 48 | 4 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 181 | 48 | 4 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 181 | 48 | 4 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.29e-05 | 181 | 48 | 4 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.29e-05 | 181 | 48 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 181 | 48 | 4 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.39e-05 | 182 | 48 | 4 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 4.39e-05 | 182 | 48 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-05 | 183 | 48 | 4 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-05 | 183 | 48 | 4 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.58e-05 | 184 | 48 | 4 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.58e-05 | 184 | 48 | 4 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.58e-05 | 184 | 48 | 4 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.58e-05 | 184 | 48 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.67e-05 | 185 | 48 | 4 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.67e-05 | 185 | 48 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 4.67e-05 | 185 | 48 | 4 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.67e-05 | 185 | 48 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.67e-05 | 185 | 48 | 4 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.67e-05 | 185 | 48 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-05 | 186 | 48 | 4 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-05 | 186 | 48 | 4 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.77e-05 | 186 | 48 | 4 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.77e-05 | 186 | 48 | 4 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 186 | 48 | 4 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 186 | 48 | 4 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 187 | 48 | 4 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.87e-05 | 187 | 48 | 4 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.87e-05 | 187 | 48 | 4 | 88f785932e67c613db0dda84496de351359ed962 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-05 | 187 | 48 | 4 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.87e-05 | 187 | 48 | 4 | 8896a00b30d11b90ca42726d4e122174a30b161b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 187 | 48 | 4 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 4.87e-05 | 187 | 48 | 4 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 187 | 48 | 4 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 4.98e-05 | 188 | 48 | 4 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.98e-05 | 188 | 48 | 4 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 4.98e-05 | 188 | 48 | 4 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-05 | 188 | 48 | 4 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-05 | 188 | 48 | 4 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.98e-05 | 188 | 48 | 4 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.98e-05 | 188 | 48 | 4 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.98e-05 | 188 | 48 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.98e-05 | 188 | 48 | 4 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.98e-05 | 188 | 48 | 4 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-05 | 189 | 48 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.08e-05 | 189 | 48 | 4 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.08e-05 | 189 | 48 | 4 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 5.08e-05 | 189 | 48 | 4 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-05 | 189 | 48 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-05 | 189 | 48 | 4 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 5.08e-05 | 189 | 48 | 4 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.08e-05 | 189 | 48 | 4 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 5.08e-05 | 189 | 48 | 4 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.08e-05 | 189 | 48 | 4 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 5.08e-05 | 189 | 48 | 4 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.08e-05 | 189 | 48 | 4 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.18e-05 | 190 | 48 | 4 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-05 | 190 | 48 | 4 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-05 | 190 | 48 | 4 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.18e-05 | 190 | 48 | 4 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.18e-05 | 190 | 48 | 4 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 5.18e-05 | 190 | 48 | 4 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.18e-05 | 190 | 48 | 4 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.18e-05 | 190 | 48 | 4 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 5.18e-05 | 190 | 48 | 4 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.18e-05 | 190 | 48 | 4 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 48 | 4 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.29e-05 | 191 | 48 | 4 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 191 | 48 | 4 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 191 | 48 | 4 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.29e-05 | 191 | 48 | 4 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 191 | 48 | 4 | dad675251e129254955eac179c84a641a4864586 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.29e-05 | 191 | 48 | 4 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 5.29e-05 | 191 | 48 | 4 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 191 | 48 | 4 | 6d2cf41ee946137c039ddcc13593fc3f670afbba | |
| Computational | Genes in the cancer module 267. | 7.05e-06 | 15 | 28 | 3 | MODULE_267 | |
| Drug | beta-erythroidine | 3.29e-08 | 4 | 47 | 3 | ctd:C004873 | |
| Drug | NSC7524 | 8.92e-08 | 182 | 47 | 7 | CID000005657 | |
| Drug | decamethonium | 1.64e-07 | 6 | 47 | 3 | ctd:C033019 | |
| Drug | Dimethylphenylpiperazinium Iodide | 4.58e-07 | 8 | 47 | 3 | ctd:D004246 | |
| Drug | epibatidine | 4.58e-07 | 8 | 47 | 3 | ctd:C082748 | |
| Drug | Excitatory Amino Acid Antagonists | 6.87e-07 | 9 | 47 | 3 | ctd:D018691 | |
| Drug | pozanicline | 6.87e-07 | 9 | 47 | 3 | ctd:C108326 | |
| Drug | N-methyl-DL-aspartic acid | SLC6A9 CACNA1F GRIN2B CIT SGCB ADCY1 PTGS1 CHRNA4 CHRNB2 RYR3 | 7.18e-07 | 655 | 47 | 10 | CID000004376 |
| Drug | cytisine | 1.34e-06 | 11 | 47 | 3 | ctd:C004712 | |
| Drug | AC1O3MDH | 2.16e-06 | 102 | 47 | 5 | CID006332158 | |
| Drug | halothane | 3.48e-06 | 314 | 47 | 7 | CID000003562 | |
| Drug | subecholine | 4.17e-06 | 2 | 47 | 2 | ctd:C009335 | |
| Drug | 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole | 4.17e-06 | 2 | 47 | 2 | ctd:C088383 | |
| Drug | ispronicline | 4.17e-06 | 2 | 47 | 2 | ctd:C490152 | |
| Drug | 5-(2-azetidinylmethoxy)-2-chloropyridine | 4.17e-06 | 2 | 47 | 2 | ctd:C109763 | |
| Drug | metanicotine | 4.17e-06 | 2 | 47 | 2 | ctd:C012419 | |
| Drug | 3-(2-(pyrrolidinyl)methoxy)pyridine | 4.17e-06 | 2 | 47 | 2 | ctd:C116733 | |
| Drug | Bridged Bicyclo Compounds, Heterocyclic | 4.17e-06 | 2 | 47 | 2 | ctd:D019086 | |
| Drug | TC 2559 | 4.17e-06 | 2 | 47 | 2 | ctd:C419442 | |
| Drug | Fire Trol 934 | 4.17e-06 | 2 | 47 | 2 | ctd:C508049 | |
| Drug | Pyrazines | 4.53e-06 | 16 | 47 | 3 | ctd:D011719 | |
| Drug | Hexamethonium | 4.53e-06 | 16 | 47 | 3 | ctd:D018738 | |
| Drug | Calcium | 6.84e-06 | 493 | 47 | 8 | ctd:D002118 | |
| Drug | AC1L1IZE | 7.38e-06 | 131 | 47 | 5 | CID000004799 | |
| Drug | nicardipine | 1.21e-05 | 145 | 47 | 5 | CID000004473 | |
| Drug | ponceau 4R | 1.25e-05 | 3 | 47 | 2 | ctd:C576297 | |
| Drug | 13,19-didesmethyl spirolide C | 1.25e-05 | 3 | 47 | 2 | ctd:C544516 | |
| Drug | sazetidine-A | 1.25e-05 | 3 | 47 | 2 | ctd:C514816 | |
| Drug | Alcuronium | 1.25e-05 | 3 | 47 | 2 | ctd:D000443 | |
| Drug | A 85380 | 1.25e-05 | 3 | 47 | 2 | ctd:C104288 | |
| Drug | 13-desmethylspirolide C | 1.25e-05 | 3 | 47 | 2 | ctd:C517170 | |
| Drug | desformylflustrabromine | 1.25e-05 | 3 | 47 | 2 | ctd:C524215 | |
| Drug | brilliant blue | 1.25e-05 | 3 | 47 | 2 | ctd:C006796 | |
| Drug | Barium | 1.48e-05 | 72 | 47 | 4 | ctd:D001464 | |
| Drug | sodium nitroprusside | 1.55e-05 | 261 | 47 | 6 | CID000045469 | |
| Drug | caffeine | 1.77e-05 | 562 | 47 | 8 | CID000002519 | |
| Drug | 7-NI | 2.03e-05 | 78 | 47 | 4 | CID000001893 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | 2.13e-05 | 577 | 47 | 8 | CID000000295 | |
| Drug | Anabasine | 2.50e-05 | 4 | 47 | 2 | ctd:D000691 | |
| Drug | Amaranth Dye | 2.50e-05 | 4 | 47 | 2 | ctd:D000548 | |
| Drug | 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane | 2.50e-05 | 4 | 47 | 2 | ctd:C569671 | |
| Drug | Acetylthiocholine | 2.50e-05 | 4 | 47 | 2 | ctd:D000122 | |
| Drug | Succinylcholine | 2.50e-05 | 4 | 47 | 2 | ctd:D013390 | |
| Drug | flazin | 2.50e-05 | 4 | 47 | 2 | CID005377686 | |
| Drug | alpha-conotoxin MII | 2.50e-05 | 4 | 47 | 2 | ctd:C098872 | |
| Drug | U46619 | 2.55e-05 | 285 | 47 | 6 | CID000005618 | |
| Drug | memantine | 2.99e-05 | 86 | 47 | 4 | CID000004054 | |
| Drug | AC1LALA3 | 3.22e-05 | 30 | 47 | 3 | CID000490573 | |
| Drug | sodium alpha-oxyhyponitrite | 3.22e-05 | 30 | 47 | 3 | CID010129945 | |
| Drug | metolachlor | 3.27e-05 | 88 | 47 | 4 | CID000004169 | |
| Drug | tetracaine | 3.27e-05 | 88 | 47 | 4 | CID000005411 | |
| Drug | Allura Red AC Dye | 4.15e-05 | 5 | 47 | 2 | ctd:C005915 | |
| Drug | N-(1,2,3,4-tetrahydro-1-naphthyl)-4-nitroaniline | 4.15e-05 | 5 | 47 | 2 | ctd:C524978 | |
| Drug | cisatracurium | 4.15e-05 | 5 | 47 | 2 | ctd:C101584 | |
| Drug | methyllycaconitine | 4.31e-05 | 33 | 47 | 3 | ctd:C054634 | |
| Drug | p-nitrophenyl phosphate | 4.89e-05 | 194 | 47 | 5 | CID000000378 | |
| Drug | gamma-aminobutyric acid | 4.96e-05 | 474 | 47 | 7 | CID000000119 | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 3821_DN | |
| Drug | EPTC | 5.15e-05 | 35 | 47 | 3 | CID000012968 | |
| Drug | BAPTA | 5.21e-05 | 324 | 47 | 6 | CID000104751 | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 4120_UP | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; HL60; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 3039_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; HL60; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 2569_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 5.39e-05 | 198 | 47 | 5 | 3973_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 3205_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; PC3; HT_HG-U133A | 5.52e-05 | 199 | 47 | 5 | 4648_UP | |
| Drug | PhTX-343 | 5.61e-05 | 36 | 47 | 3 | CID000159548 | |
| Drug | enprofylline | 5.61e-05 | 36 | 47 | 3 | CID000001676 | |
| Drug | Pyridines | 6.22e-05 | 6 | 47 | 2 | ctd:D011725 | |
| Drug | Food Coloring Agents | 6.22e-05 | 6 | 47 | 2 | ctd:D005505 | |
| Drug | Nicotine | 6.22e-05 | 6 | 47 | 2 | DB00184 | |
| Drug | Tartrazine | 6.22e-05 | 6 | 47 | 2 | ctd:D013645 | |
| Drug | Lobeline | 8.70e-05 | 7 | 47 | 2 | ctd:D008120 | |
| Drug | mivacurium | 8.70e-05 | 7 | 47 | 2 | ctd:C049430 | |
| Drug | Chlorisondamine | 8.70e-05 | 7 | 47 | 2 | ctd:D002714 | |
| Drug | EPTC | 8.70e-05 | 7 | 47 | 2 | ctd:C036251 | |
| Drug | Atracurium | 8.70e-05 | 7 | 47 | 2 | ctd:D001279 | |
| Drug | Indigo Carmine | 8.70e-05 | 7 | 47 | 2 | ctd:D007203 | |
| Drug | 3,5-dibromo-2-(2,4-dibromophenoxy)phenol | 8.70e-05 | 7 | 47 | 2 | ctd:C085794 | |
| Drug | lamotrigine | 9.63e-05 | 116 | 47 | 4 | CID000003878 | |
| Drug | dihydro-beta-erythroidine | 1.03e-04 | 44 | 47 | 3 | CID000031762 | |
| Drug | philanthotoxin | 1.10e-04 | 45 | 47 | 3 | CID000115201 | |
| Drug | potassium phosphate | 1.13e-04 | 121 | 47 | 4 | CID000024450 | |
| Drug | sodium | 1.15e-04 | 944 | 47 | 9 | CID000000923 | |
| Drug | Rivastigmine | 1.16e-04 | 8 | 47 | 2 | ctd:D000068836 | |
| Drug | FG 9041 | 1.16e-04 | 8 | 47 | 2 | ctd:C056723 | |
| Drug | NSC135065 | 1.16e-04 | 8 | 47 | 2 | CID000282014 | |
| Drug | Galantamine | 1.16e-04 | 8 | 47 | 2 | DB00674 | |
| Drug | fluo-3 | 1.17e-04 | 122 | 47 | 4 | CID000104978 | |
| Drug | Mecamylamine | 1.18e-04 | 46 | 47 | 3 | ctd:D008464 | |
| Drug | glutamate | 1.32e-04 | 962 | 47 | 9 | CID000000611 | |
| Drug | neuroNal | 1.42e-04 | 49 | 47 | 3 | CID000010535 | |
| Drug | Galantamine | 1.49e-04 | 9 | 47 | 2 | ctd:D005702 | |
| Drug | antimony trioxide | 1.49e-04 | 9 | 47 | 2 | ctd:C037554 | |
| Drug | fenoxycarb | 1.49e-04 | 9 | 47 | 2 | ctd:C052034 | |
| Drug | mepivacaine | 1.60e-04 | 51 | 47 | 3 | CID000004062 | |
| Drug | noradrealine | 1.65e-04 | 575 | 47 | 7 | CID000000951 | |
| Drug | AC1L9ZFX | 1.68e-04 | 134 | 47 | 4 | CID000504578 | |
| Drug | rolipram | 1.71e-04 | 253 | 47 | 5 | CID000005092 | |
| Drug | donepezil | 1.80e-04 | 53 | 47 | 3 | CID000003152 | |
| Disease | nicotine dependence | 6.78e-06 | 78 | 46 | 4 | EFO_0003768 | |
| Disease | Frontal Epilepsy, Benign, Childhood | 1.42e-05 | 4 | 46 | 2 | C0393671 | |
| Disease | Epilepsy, Cingulate | 1.42e-05 | 4 | 46 | 2 | C0393684 | |
| Disease | Epilepsy, Supplementary Motor | 1.42e-05 | 4 | 46 | 2 | C0393683 | |
| Disease | Epilepsy, Opercular | 1.42e-05 | 4 | 46 | 2 | C0393688 | |
| Disease | Epilepsy, Orbito-Frontal | 1.42e-05 | 4 | 46 | 2 | C0751643 | |
| Disease | Epilepsy, Anterior Fronto-Polar | 1.42e-05 | 4 | 46 | 2 | C0751642 | |
| Disease | Epilepsy, Frontal Lobe | 1.42e-05 | 4 | 46 | 2 | C0085541 | |
| Disease | Autosomal dominant nocturnal frontal lobe epilepsy | 1.42e-05 | 4 | 46 | 2 | cv:C3696898 | |
| Disease | preeclampsia, fetal genotype effect measurement | 2.37e-05 | 5 | 46 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | nicotine dependence (is_implicated_in) | 3.55e-05 | 6 | 46 | 2 | DOID:0050742 (is_implicated_in) | |
| Disease | Mental Depression | 4.67e-05 | 254 | 46 | 5 | C0011570 | |
| Disease | Sleep Disorders | 4.97e-05 | 7 | 46 | 2 | C0851578 | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 4.97e-05 | 7 | 46 | 2 | C3696898 | |
| Disease | Subwakefullness Syndrome | 4.97e-05 | 7 | 46 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 4.97e-05 | 7 | 46 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 4.97e-05 | 7 | 46 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 4.97e-05 | 7 | 46 | 2 | C0751508 | |
| Disease | Sleep Wake Disorders | 4.97e-05 | 7 | 46 | 2 | C4042891 | |
| Disease | Schizophrenia | 5.93e-05 | 883 | 46 | 8 | C0036341 | |
| Disease | Depressive disorder | 8.59e-05 | 289 | 46 | 5 | C0011581 | |
| Disease | C-reactive protein measurement | 8.68e-05 | 1206 | 46 | 9 | EFO_0004458 | |
| Disease | Withdrawal Symptoms | 1.03e-04 | 58 | 46 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.03e-04 | 58 | 46 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.03e-04 | 58 | 46 | 3 | C0038587 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.55e-04 | 12 | 46 | 2 | C1861063 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 1.83e-04 | 13 | 46 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | behavioural disinhibition measurement | 2.21e-04 | 75 | 46 | 3 | EFO_0006946 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.43e-04 | 195 | 46 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | intracerebral hemorrhage | 2.81e-04 | 16 | 46 | 2 | EFO_0005669 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 2.81e-04 | 16 | 46 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 40:6 measurement | 3.19e-04 | 17 | 46 | 2 | EFO_0010389 | |
| Disease | Attention Deficit Disorder | 5.38e-04 | 22 | 46 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 5.38e-04 | 22 | 46 | 2 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 6.42e-04 | 24 | 46 | 2 | C1263846 | |
| Disease | Alzheimer's disease (is_marker_for) | 6.88e-04 | 257 | 46 | 4 | DOID:10652 (is_marker_for) | |
| Disease | Autistic Disorder | 7.29e-04 | 261 | 46 | 4 | C0004352 | |
| Disease | pneumonia, COVID-19 | 7.36e-04 | 113 | 46 | 3 | EFO_0003106, MONDO_0100096 | |
| Disease | Alcoholic Intoxication, Chronic | 8.05e-04 | 268 | 46 | 4 | C0001973 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 8.76e-04 | 28 | 46 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | Cone-Rod Dystrophy 2 | 9.40e-04 | 29 | 46 | 2 | C3489532 | |
| Disease | parental longevity | 1.00e-03 | 494 | 46 | 5 | EFO_0007796 | |
| Disease | Epileptic encephalopathy | 1.01e-03 | 30 | 46 | 2 | C0543888 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.13e-03 | 131 | 46 | 3 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.13e-03 | 131 | 46 | 3 | C4552091 | |
| Disease | Juvenile arthritis | 1.13e-03 | 131 | 46 | 3 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.13e-03 | 131 | 46 | 3 | C3714758 | |
| Disease | microcephaly (implicated_via_orthology) | 1.14e-03 | 32 | 46 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | Juvenile-Onset Still Disease | 1.23e-03 | 135 | 46 | 3 | C0087031 | |
| Disease | primary dental caries | 1.29e-03 | 34 | 46 | 2 | EFO_0600095 | |
| Disease | emphysema imaging measurement | 1.54e-03 | 146 | 46 | 3 | EFO_0007626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPFSLTFFLNGMQVN | 346 | Q5RHP9 | |
| TFFPFDQQNCTMKFG | 166 | P43681 | |
| TQAPQFLISTGNFMY | 831 | Q96PZ7 | |
| FFTSLMQKFTFRPPN | 461 | P51589 | |
| NQMSFTFASPTQVFF | 36 | P30049 | |
| LSGFFNPQSFLTAIM | 4376 | Q96DT5 | |
| QPFFFTGAFPFNMQE | 246 | Q6AI12 | |
| FDNPATVFFSIFMAL | 436 | Q9NQ90 | |
| TFNNIMNFQRFLKFP | 311 | O14578 | |
| MLFSDSPFLQGFLQQ | 386 | Q96CP6 | |
| GLFDMFPNQFRFVGN | 1061 | P98198 | |
| QPGFSLMNFDGQVFF | 16 | P55895 | |
| ESIMNIVSGFFNSPF | 1481 | Q14571 | |
| PNGGITNFDNFFFAM | 306 | O60840 | |
| AFFSFMTHRFGQNIP | 256 | Q8NGH9 | |
| GFTNNPEMQVSLFIF | 16 | Q8NGE5 | |
| PNFSFMGQLLQFETQ | 296 | Q05923 | |
| NISPNFNFMGQLLDF | 326 | Q99956 | |
| FIPDPQGTNLMFAFF | 186 | P23219 | |
| QPVNSFGFANSYIAM | 501 | O95800 | |
| SFQEFLQSPNRVGFM | 206 | Q9H813 | |
| PLQGNSFFVMTNFLK | 96 | Q99572 | |
| FFPFDLQNCSMKFGS | 176 | P30532 | |
| QVGVMFASIPNFNDF | 866 | Q08828 | |
| SPNFSFMGQLLQFES | 296 | P28562 | |
| GVAFPFFMDNSNIVA | 56 | A6NFE3 | |
| GQKFFFSLAAVNPNF | 521 | Q9Y6N8 | |
| LNFMSNVGDPRNIFF | 26 | Q9NQR9 | |
| FLLGFQFIFASMQKP | 616 | Q04637 | |
| LTGFFNPQSFLTAIM | 4346 | Q9NYC9 | |
| FLFFGPVGFNFLFNM | 61 | Q9GZP9 | |
| NPYVRMNFFGLLNFQ | 136 | Q9GZP9 | |
| IMFIGVNLTFFPQHF | 416 | P00395 | |
| IISPNFSFMGQLLQF | 316 | Q13115 | |
| GTSMFPFQNILFIFL | 166 | P0C7X4 | |
| QPISLAGCATQMFFF | 101 | P30954 | |
| IKMGNNPFFNEIFFQ | 201 | A0AVI2 | |
| IGMQFFDPRTQNILF | 166 | Q16585 | |
| FQQMSPSRNFSFRLF | 21 | Q4LDE5 | |
| MYLQSLFTPGQFTNE | 456 | Q12769 | |
| PNGQMFVFTGFLNSV | 301 | Q96E52 | |
| FDNFAASPNLLMLAF | 471 | Q96N87 | |
| GMFLQPLFQNYTTTT | 476 | P17787 | |
| LTFGFITMTPQLFIN | 516 | O96005 | |
| FANAGMNQFKPIFLN | 41 | P49588 | |
| FENFNTDGLFFPVMS | 766 | Q15413 | |
| IPLFFMELSFGQFAS | 151 | P48067 | |
| AQSQFIANHPFLFIM | 361 | O75830 | |
| LSQHNFPQGMIFFSD | 796 | Q9BZ71 | |
| SMFFQFGPSIEQQAS | 141 | Q13224 |